Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc to acquire NuPathe Inc


Monday, 16 Dec 2013 07:00am EST 

Endo Health Solutions Inc:Enters into a definitive agreement under which Endo will acquire NuPathe Inc.For $2.85 per share in cash, or about $105 million.In addition to the upfront cash payment, NuPathe shareholders will receive rights to receive additional cash payments of up to $3.15 per share if specified net sales of NuPathe's migraine treatment ZECUITY are achieved over time.Under the terms of the merger agreement, an affiliate of Endo will promptly commence a tender offer to acquire all of the outstanding shares of NuPathe's common stock for $2.85 per share in cash and the right to receive contingent cash consideration payments of up to $3.15 per share.The transaction is expected to be completed in early 2014. 

Company Quote

73.16
1.06 +1.47%
26 Dec 2014